Adriamycin (NSC-123127) plus 5-fluorouracil (NSC-19893): a phase I study

Cancer Chemother Rep. 1975 Nov-Dec;59(6):1163-5.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Clinical Trials as Topic
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Doxorubicin / therapeutic use*
  • Drug Therapy, Combination
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Fluorouracil / therapeutic use*
  • Humans
  • Neoplasms / drug therapy*

Substances

  • Doxorubicin
  • Fluorouracil